AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2009
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
- Tax period
- 2009-06-01 to 2010-05-31
- Filed
- 2011-04-13
- IRS object ID
- 201101039349300705
- Schema version
- 2009v1.4
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule G
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2011-04-13T09:07:18-05:00 | Timestamp |
| Tax Period End Date | 2010-05-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Tate and Tryon | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2021 L Street NW Suite 400 | AddressLine1 |
| City | Washington | City |
| State | DC | State |
| ZIP Code | 20036 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2009-06-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 237033369 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM | BusinessNameLine1 |
| Business Name Line2 | PHARMACISTS RESEARCH AND EDUCATION FDTN | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | AMER | NameControl |
| Phone | 3016648612 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7272 WISCONSIN AVENUE 2ND FLOOR | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | STEPHEN J ALLEN | Name |
| Title | EXECUTIVE VICE PRESIDENT AND CEO | Title |
| Phone | 3016648612 | Phone |
| Date Signed | 2011-04-13 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | DEBORAH G KOSNETT | Name |
| Phone | 2022932200 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2009 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | STEPHEN J ALLEN | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7272 WISCONSIN AVENUE 2ND FLOOR | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 3378384 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c | X | Organization501c |
| Web Site | WWW.ASHPFOUNDATION.ORG | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 1968 | YearFormation |
| State Legal Domicile | MD | StateLegalDomicile |
| Activity Or Mission Description | FOSTERING SAFE AND EFFECITVE MEDICATION USE. TO PROMOTE THE PUBLIC INTEREST THROUGH DEVELOPMENT OF HIGH QUALITY PHARMACEUTICAL SERVICES IN HEALTH SYSTEMS. TO ENCOURAGE, PROVIDE FOR AND ENGAGE IN SCIENTIFIC RESEARCH, PROFESSIONAL STUDY AND ADVANCEMENT OF THE SCIENCE OF PHARMACY IN HEALTH SYSTEMS. TO IMPROVE THE QUALITY AND INCREASE THE AVAILABILITY OF PHARMACEUTICAL SERVICES TO THE PUBLIC. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 11 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 9 | NbrIndependentVotingMembers |
| Total Nbr Employees | 0 | TotalNbrEmployees |
| Total Nbr Volunteers | 100 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 0 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 1610656 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 1993575 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 131189 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 155612 | ProgramServiceRevenueCY |
| Investment Income Prior Year | -2139511 | InvestmentIncomePriorYear |
| Investment Income Current Year | 1220437 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | -8864 | OtherRevenuePriorYear |
| Other Revenue Current Year | -9853 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | -406530 | TotalRevenuePriorYear |
| Total Revenue Current Year | 3359771 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 564069 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 497824 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 1068454 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 1057637 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 352987 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 791819 | OtherExpensePriorYear |
| Other Expenses Current Year | 748340 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 2424342 | TotalExpensesPriorYear |
| Total Expenses Current Year | 2303801 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | -2830872 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | 1055970 | RevenuesLessExpensesCY |
| Total Assets BOY | 8730826 | TotalAssetsBOY |
| Total Assets EOY | 9832251 | TotalAssetsEOY |
| Total Liabilities BOY | 226249 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 271704 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 8504577 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 9560547 | NetAssetsOrFundBalancesEOY |
| Mission Description | The mission of the ASHP Foundation is to improve the health and well-being of patients in hospitals and health systems through appropriate, safe and effective medication use. The Foundation provides leadership and conducts education and research activities that foster the coordination of interdisciplinary medication management leading to optimal patient outcomes. Emphasis is given to programs that will have a major impact on advancing pharmacy practice in hospitals and health systems, thereby improving public health. | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 768245 | Expense |
| Grants | 132560 | Grants |
| Revenue | 155612 | Revenue |
| Description | EXPANSION OF PHARMACISTS' DIRECT PATIENT CARE AND LEADERSHIP ROLES ASHP Foundation Research Advisory Panel-The Research Advisory Panel (RAP) met once during FY 10 and the Senior Director for Research and Operations worked closely with several panel members to facilitate implementation of several RAP recommendations for the Foundation's research agenda. These included guidance on the Foundation's grant review process, research misconduct language, and the future role of the RAP.Center for Health-System Pharmacy Leadership-The Center was developed as a collaborative programmatic offering of ASHP and the ASHP Foundation, and is administered by the Foundation. The Center has been in operation since January 2007 and its primary objectives are to: (1) assure that pharmacy leaders have the knowledge necessary to proactively influence the advancement of the medication-use process by providing competency-based education opportunities, (2) provide leadership development programs for students, residents and new practitioners that promote the important role of the pharmacist as a change agent and a leader in patient care, (3) integrate into health-system leadership decision-making the critical role for pharmacists as active participants in achieving organizational objectives, (4) conduct research on effective pharmacy management and leadership in achieving the objectives of hospitals and health systems, as well as improving community disease prevention and health promotion efforts and (5) explore the purpose and value of a credential for hospital and health-system pharmacy leaders that recognizes competencies to direct the medication-use systems enterprise and promote safety and cost-effective medication outcomes.The Center Advisory Panel (CAP)-This advisory panel was established in FY 08 and is a 12-member group that serves as an external resource of experts providing an environmental scan of practice issues and significant events that might affect the Center's plan of action. In addition, members provide expert advice on the Center's current direction, program development and possible actions that the Center should consider as it builds its program portfolio. The CAP met twice in FY 10.Pharmacy Leadership Academy-The Pharmacy Leadership Academy is supported by Amgen. The Pharmacy Leadership Academy is designed to provide additional comprehensive training to pharmacy leaders beyond what is learned in pharmacy residencies, short courses and other educational programs. The Academy provides leadership training applicable to clinical and administrative pharmacy practitioners in small to large hospitals and health systems who aspire to leadership positions in health-system pharmacy.Leadership Learning Community-The Center for Health-System Pharmacy Leadership hosted a successful learning community at the June 2010 ASHP Summer Meeting entitled "Leading Results with NQF 18." The 5-session series offered over 11 hours of material and had an esteemed faculty of senior pharmacists and health-system executives from a variety of health-system settings.Pharmacy Leadership Institute (PLI)-Since 2008, the Section for Pharmacy Practice Managers has collaborated with Boston University to establish the PLI as a major program within the Center's portfolio and to have it serve as its capstone program. The Pharmacy Leadership Institute uses relevant program curriculum, high-quality instruction, and peer interaction to broaden business skills, managerial versatility, and the extraordinary leadership demanded of today's health-system pharmacy leaders. The experience enables pharmacist leaders to develop a new way of thinking and a new set of behaviors to meet the demanding challenges facing pharmacy. PLI graduates have become a source of leadership experts serving the Center's initiatives.Conversations with Health-System Pharmacy's Most Influential Leader's Video-ASHP past president and Whitney Award Recipient, Sara White, provided the Foundation with ongoing support and volunteered her time to help produce a series of videos with some of the most influential health-system pharmacy practice leaders. The videos are hosted on the ASHP Foundation Web site as a leadership resource and a source of motivation for health-system pharmacy professionals. Two new videos were added in the fall of 2009, expanding the total of videos to nine.Leadership Speakers Bureau-The Leadership Speakers Bureau (LSB) is the first program of the Center for Health-System Pharmacy Leadership developed specifically for students. The LSB is a collaboration of the Center and ASHP's Section of Pharmacy Practice Managers, Student and New Practitioners Forum, and the State Affiliates Division, along with external consultants. Pharmacists who are ASHP state affiliate members are the primary speakers. They draw upon their personal and professional experiences to encourage students to embrace leadership as part of their professional obligation. Supported by a grant from Roche, 14 schools of pharmacy participated in the program during FY 10.Community Health Systems Leadership Seminar Series-In February, 2010, the Center for Health-System Pharmacy Leadership launched an eight-month leadership seminar series for the pharmacists employed by Community Health Systems (CHS), the nation's third largest health system. This program has been customized to meet the key leadership needs and challenges for the CHS pharmacy leadership team across the nation. Topics include leadership subjects that have been presented in past leadership learning communities sponsored by the Center at the ASHP Summer Meeting, and are presented via live, web-based distance learning mechanisms.Leadership Resource Center- Sponsored by Baxter Healthcare, Inc., this program was developed in 2009 and launched in February of 2010 as a web-based resource that is part of the ASHP Foundation's website. The primary goal of the Leadership Resource Center is to have an ongoing and continuously updated source of leadership information and tools to assist pharmacists at all stages of their careers.Student Leadership Development Workshop-The Center for Health-System Pharmacy leadership worked with the Section of Pharmacy Practice Managers to support a series of three-hour leadership development workshops for pharmacy students at three ASHP state affiliate meetings. Discussions are underway to determine how to make this workshop an ongoing program supported by the ASHP Foundation.Pharmacy Student Clinical Skills Competition-This is the third year that the Foundation has sponsored the Pharmacy Student Clinical Skills Competition (CSC) at the ASHP Midyear Clinical Meeting. Each year the number of participating schools continues to grow and in December 2009 102 teams who won preliminary competitions at their local pharmacy schools participated in the competition. During the CSC, students demonstrate their skills by assessing patient information and current therapy, identifying and prioritizing drug therapy problems, identifying treatment goals, and recommending a pharmacist care plan. The 2009 recipients were Tamara Spraker and Sijy Mathew of the University of Texas at Austin.Demonstrating Pharmacists' Value: A Systematic Evidence Review-Dr. Marie Chisholm-Bums of the University of Arizona completed a systematic evidence review entitled "Demonstrating Pharmacists' Impact on Therapeutic, Safety, Humanistic and Economic Health Outcomes: A Systematic Review and Meta-analyses." She presented her review at the 2009 ASHP Midyear Clinical Meeting.Harvey A. K. Whitney Award Lecture Collection Program-The Harvey A.K. Whitney Award is the most prestigious award in health-system pharmacy. The Whitney Lecture Collection Program includes a web-based program for dissemination of Whitney lectures, a dessert reception following the Whitney Award dinner at the ASHP Summer Meeting, and a reception at the ASHP Midyear Clinical Meeting that enables residents to meet many of the recipients of the Whitney award. Recipients present a lecture at the award ceremony, which is later published. Since 1990, the ASHP Foundation has offered a compilation of these lectures from 1950 through present day to residents, residency directors and directors of pharmacy participating in ASHP-accredited residency programs. The current web-based site provides access to 60 lectures that can be browsed by title, author, publication date or keyword. Updates for the 2010 year include the addition of Charles D. Hepler's lecture and the addition of brief video clips containing 6 to 8 of the past recipients.Other programs-Literature Awards ProgramPharmacy Practice Model InitiativeResearch Boot CampSterile Products Outsourcing ToolWalter Jones Memorial Pharmacy Student Financial AidASHP Student Leadership AwardWilliam A. Zellmer Leadership Lecture Program | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 548257 | Expense |
| Grants | 212275 | Grants |
| Description | ADVANCEMENT OF OPTIMAL PATIENT MEDICATION OUTCOMES:ASHP Foundation Junior Investigator Research Grant-Twenty-five applications were received for the ASHP Foundation Junior Investigator Research Grant during the FY 10 cycle. This grant is offered to new pharmacist investigators and is intended to support practice-based medication-use research. Grant funds are provided by the ASHP Foundation through Joseph A. Oddis Endowment. A seven-member review panel composed of pharmacist and physician researchers recommended award of the following grants: "Nonadherence with INR Monitoring and Anticoagulant Complications" which will be conducted by Daniel M. Witt, Pharm.D., of Kaiser Permanente Colorado and Mark A. Crowther, M.D. of McMaster University and "Improving Pharmacist-led Electronic Medication Reconciliation" which will be conducted by Shobha Phansalkar, R.Ph., Ph.D and David Bates, M.D. of The Brigham and Woman's Hospital. Studies funded during the FY 08 and FY 09 grant cycles progressed during FY 10.American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship-The ASHP Foundation withheld its annual funding of the AFPE Pre-Doctoral Fellowship in the spring of 2009 but was able to partner with ASHP in May of 2010 to jointly fund this fellowship in the coming year. We are awaiting the selection of the student in 2010 who will benefit from the ASHP/ASHP Foundation support.Antithrombotic Pharmacotherapy Traineeship Program-In collaboration with ASHP as part of a multi-tiered educational program, the Foundation received funding for the 2009/2010 Antithrombotic Pharmacotherapy Traineeship from sanofi-aventis. The 2009/2010 program offering was revised to include a comprehensive web-based distance education program and comparison of anti thrombotic medication related pre/post process and patient outcomes. The traineeship concluded with a 5-day structured experiential program that prepared pharmacists to establish and maintain specialized services for the management of patients' antithrombotic therapy.Critical Care Traineeship Program-This program was last conducted in May 2009 and was a program that was unfunded in FY 10. Staff continues to seek programmatic support for what is one of the most popular traineeship programs. Fed. Services Jr. Invest. Grant Program: Optimizing Chronic Drug Therapy in the Elderly- For FY 07 through FY 09, program support was provided by Abbott and the research focus was medication adherence in patients with either auto-immune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. Research supported by the FY 07, FY 08 and FY 09 programs is ongoing.Hospital Pharmacist - Hospitalist Collaborations-Sanofi-aventis provided sponsorship for this program that studies multidisciplinary initiatives between hospitalists and hospital pharmacists focused on venous thromboembolism prevention/treatment or glycemic control in hospitalized patients. Research from these two programs from FY 07 and FY 08 is ongoing. FY 07 recipient Dr. Rachel Hroncich presented findings at the 2009 ASHP Midyear Clinical Meeting.Emergency Physician/Hospital Pharmacist Research Grant Program-Ortho-McNeil provided sponsorship for this program which supports research, conducted by hospital pharmacists and emergency physicians, related to the care of patients with infectious diseases who present to the emergency department. A ten-member review panel composed of pharmacists and emergency physicians recommended award of the following grants: "ED Pharmacists Optimize Antimicrobial Use Process in Severe Sepsis and Septic Shock," which will be conducted by Maria l. Rudis, Pharm.D. and Christopher S. Russi, D.O. of Mayo Clinic Rochester and "The Value of MRSA Nares Carriage Status for Treatment of Skin and Soft Infections in the Emergency Department," which will be conducted by Nicole M. Acquisto, Pharm.D. and Sharon G. Humiston, M.D., M.P.H. of the University of Rochester Medical Center.Oncology Patient Care Traineeship Program-Support for the 2009/2010 program was provided by Amgen. Eight trainees were selected from 24 applicants. Participants received their experiential training at the following four sites: Duke University Medical Center, The Johns Hopkins Hospital, University of Texas M.D. Anderson Cancer Center, and the University of Washington Medical Center. Pain and Palliative Care Traineeship Program-Endo Pharmaceuticals provided support for redesign of the former Pain Management Traineeship to expand its focus to include palliative care and to transform the distance education component to reach more pharmacists. The distance education program will include a Pain Management and Palliative Care Self-Assessment Tool and modules to address application of the principles of pain management and palliative care.Pharmacy Residency Excellence Awards Program-The 2009 Pharmacy Residency Excellence Awards Program was supported by Amgen, Inc. This unique national competition recognizes excellence and leadership in the training and mentoring of pharmacy residents. The objectives of this program are to: (1) recognize the achievements of residency programs and pharmacists who have demonstrated excellence and leadership in the training of pharmacy residents, and (2) to widely disseminate the results of these accomplishments to foster innovations in pharmacy resident training.Pharmacy Resident Practice-Based Research Grant Program-Sixty-five applications were received for the 2009 Pharmacy Resident Practice-Based Research Grant Program. This program was funded through the ASHP dues contribution to the Foundation. This grant is offered to pharmacy residents participating in an ASHP-accredited residency program and is intended to support health services research related to medication use.Promoting Influenza Prevention: Pharmacists as Immunization Advocates-CSL Biotherapies provided support for Promoting Influenza Prevention: Pharmacists as Immunization Advocates. This program supports demonstration projects that focus on the pharmacist's role in promoting vaccination against seasonal influenza. Two $25,000 grants are being offered through this program. Twelve applications were received for the April 16, 2010 deadline. Grantees selection is occurring during FY 11 and the research will begin during the 2010/2011 flu season.University of Alabama Musculoskeletal CERTs-Foundation staff members, Drs. Daniel Cobaugh and Cynthia LaCivita continued to collaborate with the Agency for Health Care Research and Quality (AHRQ)-funded Musculoskeletal Center for Education and Research in Therapeutics (CERTs) at the University of Alabama. In FY 10, this collaboration resulted in two publications: (1) Miller MJ, Allison JJ, Schmitt MR, Ray MN, Funkhouser EM, Cobaugh DJ, Saag KG, LaCivita C. using single-item health literacy screening questions to identify patients who read written nonsteroidal antiinflammatory medicine information provided at pharmacies; (2) Miller MJ, Schmitt MR, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. Multi-Site Unsolicited Grant-In April 2008, the ASHP Foundation made a grant award to Jeffrey Rothschild, M.D. and William Churchill, R.Ph., of the Brigham and Women's Hospital, for a study entitled "Medication Errors Recovered by Emergency Department Pharmacists." This multicenter study also included the University of Wisconsin Hospitals and Clinics and Cedars Sinai Medical Center. The results of this study were presented at the 2009 Scientific Congress of the American College of Emergency Physicians and at the 2009 ASHP Midyear Clinical Meeting. Dr. Rothchild's research was also published in the Annals of Emergency Medicine. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 472448 | Expense |
| Grants | 152991 | Grants |
| Description | DESIGN AND STUDY OF SAFE AND EFFECTIVE MEDICATION-USE SYSTEMS:2009 Award for Excellence in Medication-Use Safety-Supported by a grant from the Cardinal Health Foundation, this program is designed to recognize a pharmacist-led multidisciplinary team that makes significant institution-wide system improvements relating to medication use. The program is in its sixth year and is the only national-level program that recognizes the pharmacist's leadership role in the medication-use process. The three 2009 finalist organizations were chosen from 34 applicants using structured selection criteria established by an independent multidisciplinary panel of experts in the field of medication safety and healthsystem administration. The Women & Children's Hospital of Buffalo Kaleida Health System, NY received the $50,000 award. The two finalists, Henry Ford Hospital in Detroit, MI and Rex Healthcare in Raleigh, NC each received $10,000. The 2009 Award for Excellence video highlighted the success stories of the recipient and finalists and was presented to more than 8,000 pharmacists at the 2009 ASHP Midyear Clinical Meeting opening general session in December in Las Vegas, NY. A dinner was also held at the Midyear to recognize the finalist and recipient teams.Medication Safety Team Grant: Optimizing Bedside Technology Solutions-The three-year commitment from Omnicell to support this program ended in May of 2009. Research by the six recipients of this grant over a 3-year period is ongoing. Presentations by four of the grant recipients are planned for the 2010 ASHP Midyear Clinical meeting. These researchers have also begun to prepare manuscripts for submission to biomedical journals.Medication Continuity of Care Record Research-This program evaluation, sponsored with support from sanofi-aventis, is ongoing at the University of Pittsburgh School of Pharmacy. This evaluation, entitled "Development of a Continuity of Care Record: Bridging the Medication-Use Gap from Hospital to Home," is being conducted by Kim C. Coley, Pharm.D. She is studying the use of a continuity of care record and medication therapy management in the transition of patients from hospital to home.Pandemic Influenza Assessment Tool-Roche provided a grant to develop a Pandemic Readiness and Emergency Preparedness Resource Center which is available at www.pharmacyready.org. This site contains the Pandemic Influenza Assessment Tool for Health-System Pharmacy Departments(TM) along with practice resources, RSS feeds and benchmarking data. The availability of this tool was communicated to ASHP members and other health professionals through more than 40 dissemination vehicles, including the ASHP Foundation and ASHP web sites, electronic newsletters, ASHP meeting communications, and social networking sites. Between June 2009 and May 2010, during an H1N1 influenza pandemic, there were over 150,000 visits to this web-based tool.University of Iowa Medication Safety Grant-Following publication of their primary article related to this 2005 ASHP Foundation grant, Frank H. Morris, Jr., M.D and Paul W. Abramowitz, Pharm.D., of the University of Iowa Medical Center, published additional findings related to nursing perceptions about barcode-supported medication administration. (See: Morriss FH Jr, Abramowitz PW, Carmen L, Wallis AB. "Nurses Don't Hate Change" -- survey of nurses in a neonatal intensive care unit regarding the implementation, use and effectiveness of a bar code medication administration system. | Description |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expense | 1788950 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 0 | LobbyingActivities |
| Donor Advised Funds | 0 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 0 | CollectionsOfArt |
| Credit Counseling | 0 | CreditCounseling |
| Term Or Permanent Endowments | 1 | TermOrPermanentEndowments |
| Balance Sheet Amounts Reported | 1 | BalanceSheetAmountsReported |
| Independent Audit Financial Stmt | 1 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 0 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 0 | ForeignOffice |
| Foreign Activities | 0 | ForeignActivities |
| More Than5000 K To Organizations | 0 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 1 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 1 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 0 | TaxExemptBonds |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 0 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 0 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 0 | DisregardedEntity |
| Related Entity | 1 | RelatedEntity |
| Related Org Controlled Entity | 0 | RelatedOrgControlledEntity |
| Transfers To Exempt Non Chrtbl Org | 1 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Number Forms Transmitted With1096 | 42 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Compliance With Backup Witholding | 1 | ComplianceWithBackupWitholding |
| Number Of Employees | 0 | NumberOfEmployees |
| Unrelated Business Income | 0 | UnrelatedBusinessIncome |
| Foreign Financial Account | 0 | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 1 | QuidProQuoContributions |
| Quid Pro Quo Disclosure | 1 | QuidProQuoDisclosure |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | 0 | FundsToPayPremiums |
| Premiums Paid | 0 | PremiumsPaid |
| Form8899 Filed | 0 | Form8899Filed |
| Form1098 C Filed | 0 | Form1098CFiled |
| Nbr Voting Governing Body Members | 11 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 9 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 1 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 0 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 0 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 1 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 0 | MinutesOfCommittees |
| Officer Mailing Address | 0 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 1 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 0 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ELIZABETH HARTNETT | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 3016648612 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7272 WISCONSIN AVENUE 2ND FLOOR | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (15 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | OfficerOfficer | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|
| DAVID R GAUGH | |||||||
| CHAIR | 1.00 | X | X | 0 | 0 | 0 | |
| JANET A SILVESTER MBA | |||||||
| VICE CHAIR | 1.00 | X | X | 0 | 0 | 0 | |
| HENRI R MANASSE JR P | |||||||
| PRESIDENT/ASHP PRESIDENT | 1.00 | X | X | 0 | 644199 | 74836 | |
| PAUL W ABRAMOWITZ PHAR | |||||||
| TREASURER | 1.00 | X | X | 0 | 0 | 0 | |
| STEPHEN J ALLEN MS FA | |||||||
| SECRETARY/EVP | 40.00 | X | X | 217376 | 0 | 29535 | |
| BARBARA BALIK RN MS E | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| KEVIN J COLGAN MA FA | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 5000 | 0 | ||
| MICHAEL S FLAGSTAD MS | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| DALLAS J HOWE | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| BRUCE E SCOTT PHARMD | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| GORDON S WILLCOX | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| RICHARD WALLING | |||||||
| Director Ctr for Health- | 40.00 | 135636 | 0 | 14825 | X | ||
| DANIEL COBAUGH | |||||||
| Sr Dir for Research and | 40.00 | 127533 | 0 | 20132 | X | ||
| Myrna Konajeski | |||||||
| DIR OF DEVELOPMENT | 40.00 | 103863 | 0 | 2056 | X | ||
| cynthia lacivita | |||||||
| dir education and specia | 40.00 | 104487 | 0 | 12259 | X | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 688895 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 649199 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 153643 | TotalOtherCompensation |
| Number Individuals GT100 K | 5 | NumberIndividualsGT100K |
| Formers Listed | 0 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
| Number Of Contractors GT100 K | 0 | NumberOfContractorsGT100K |
| Fundraising Events | 32747 | FundraisingEvents |
| All Other Contributions | 1960828 | AllOtherContributions |
| Total Contributions | 1993575 | TotalContributions |
Program Service Revenue ProgramServiceRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | PHARMACY LEADERSHIP AC | Description |
| Business Code | 900099 | BusinessCode |
| Total Revenue Column | 155612 | TotalRevenueColumn |
| Related Or Exempt Function Income | 155612 | RelatedOrExemptFunctionIncome |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | 155612 | TotalProgramServiceRevenue |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 234758 | TotalRevenueColumn |
| Exclusion | $234,758 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 985679 | Securities |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 985679 | Securities |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 985679 | TotalRevenueColumn |
| Exclusion | $985,679 | ExclusionAmount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Income Fundraising Events | 8760 | GrossIncomeFundraisingEvents |
| Cntrbtns Rprtd Fundraising Events | 32747 | CntrbtnsRprtdFundraisingEvents |
| Fundraising Direct Expenses | 18613 | FundraisingDirectExpenses |
Net Income From Fundraising Events NetIncomeFromFundraisingEvents
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -9853 | TotalRevenueColumn |
| Exclusion | -$9,853 | ExclusionAmount |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 3359771 | TotalRevenueColumn |
| Related Or Exempt Function Income | 155612 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 0 | UnrelatedBusinessRevenue |
| Exclusion | $1,210,584 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 421110 | Total |
| Program Services | 421110 | ProgramServices |
Grants To Domestic Individuals GrantsToDomesticIndividuals
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 76714 | Total |
| Program Services | 76714 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 251190 | Total |
| Program Services | 166486 | ProgramServices |
| Management And General | 12880 | ManagementAndGeneral |
| Fundraising | 71824 | Fundraising |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 671102 | Total |
| Program Services | 445880 | ProgramServices |
| Management And General | 29850 | ManagementAndGeneral |
| Fundraising | 195372 | Fundraising |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 44810 | Total |
| Program Services | 30448 | ProgramServices |
| Management And General | 3752 | ManagementAndGeneral |
| Fundraising | 10610 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 41309 | Total |
| Program Services | 24103 | ProgramServices |
| Management And General | 5105 | ManagementAndGeneral |
| Fundraising | 12101 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 49226 | Total |
| Program Services | 38248 | ProgramServices |
| Management And General | 3666 | ManagementAndGeneral |
| Fundraising | 7312 | Fundraising |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 9600 | Total |
| Management And General | 9600 | ManagementAndGeneral |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 24330 | Total |
| Program Services | 18995 | ProgramServices |
| Management And General | 1185 | ManagementAndGeneral |
| Fundraising | 4150 | Fundraising |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 56790 | Total |
| Program Services | 31206 | ProgramServices |
| Management And General | 11948 | ManagementAndGeneral |
| Fundraising | 13636 | Fundraising |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 127006 | Total |
| Program Services | 100596 | ProgramServices |
| Management And General | 22743 | ManagementAndGeneral |
| Fundraising | 3667 | Fundraising |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 46400 | Total |
| Program Services | 29356 | ProgramServices |
| Management And General | 17044 | ManagementAndGeneral |
Other Expenses OtherExpenses (5 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| CONTRACT SERVICES | 392999 | 343233 | 34146 | 15620 |
| GENERAL EXPENSES | 94545 | 76578 | 2499 | 15468 |
| temporary services | 9220 | 4610 | 1383 | 3227 |
| bank charges and misc | 6063 | 6063 | ||
| SPECIAL EVENT EXPENSE T | -18613 | -18613 |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2303801 | Total |
| Program Services | 1788950 | ProgramServices |
| Management And General | 161864 | ManagementAndGeneral |
| Fundraising | 352987 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 703376 | BOY |
| EOY | 1019149 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 156062 | BOY |
| EOY | 214572 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2918 | BOY |
| EOY | 9325 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 195413 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 130081 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 82685 | BOY |
| EOY | 65332 | EOY |
Investments Pub Traded Securities InvestmentsPubTradedSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 7687225 | BOY |
| EOY | 8377415 | EOY |
Other Assets Total OtherAssetsTotal
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 98560 | BOY |
| EOY | 146458 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 8730826 | BOY |
| EOY | 9832251 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 114368 | BOY |
| EOY | 194520 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 59406 | BOY |
| EOY | 77184 | EOY |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 52475 | BOY |
| EOY | 0 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 226249 | BOY |
| EOY | 271704 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1467454 | BOY |
| EOY | 1869549 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2266374 | BOY |
| EOY | 2912954 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 4770749 | BOY |
| EOY | 4778044 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 8504577 | BOY |
| EOY | 9560547 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 8730826 | BOY |
| EOY | 9832251 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
| Audit Committee | 0 | AuditCommittee |
| Financial Statement Separate | X | FinancialStatementSeparate |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Supporting Organization509a3 | X | SupportingOrganization509a3 |
| Supporting Org509a3 Type1 | X | SupportingOrg509a3Type1 |
| Contrib By Controlling Individual | 0 | ContribByControllingIndividual |
| Contribution By Related Party | 0 | ContributionByRelatedParty |
| Contrib By35 Controlled Entity | 0 | ContribBy35ControlledEntity |
Supported Org Information SupportedOrgInformation
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 520807628 | EIN |
| Type Of Organization | 501(c)(6) | TypeOfOrganization |
| Listed In Governing Doc | 0 | ListedInGoverningDoc |
| Supported Organization Notified | 1 | SupportedOrganizationNotified |
| Organized In US | 1 | OrganizedInUS |
| Amount | $26,682 | Amount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of Supported Orgs | 1 | TotalNumberOfSupportedOrgs |
| Sum Of Amounts | 26682 | SumOfAmounts |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule D IRS990ScheduleD
Current Year CurrentYear
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5554292 | BeginningOfYearBalance |
| Contributions | 7295 | Contributions |
| Investment Earnings Or Losses | 899095 | InvestmentEarningsOrLosses |
| Other Expenditures | 526354 | OtherExpenditures |
| End Of Year Balance | 5934328 | EndOfYearBalance |
Current Year Minus1 Year CurrentYearMinus1Year
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 6505305 | BeginningOfYearBalance |
| Contributions | 900 | Contributions |
| Investment Earnings Or Losses | -1659001 | InvestmentEarningsOrLosses |
| Other Expenditures | -707088 | OtherExpenditures |
| End Of Year Balance | 5554292 | EndOfYearBalance |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated EOY Balance | 0.19480 | BoardDesignatedEOYBalance |
| Permanent Endowment EOY Balance | 0.80520 | PermanentEndowmentEOYBalance |
| Term Endowment EOY Balance | 0.00000 | TermEndowmentEOYBalance |
| Endowments Held By Unrelated Orgs | 0 | EndowmentsHeldByUnrelatedOrgs |
| Endowments Held By Related Orgs | 0 | EndowmentsHeldByRelatedOrgs |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 195413 | OtherCostOrOtherBasis |
| Depreciation | 130081 | Depreciation |
| Book Value | 65332 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 65332 | TotalOfBookValueLandBuildings |
| Total Revenue | 3359771 | TotalRevenue |
| Total Expenses | 2303801 | TotalExpenses |
| Excess Or Deficit For Year | 1055970 | ExcessOrDeficitForYear |
| Total Adjustments | 0 | TotalAdjustments |
| Excess Or Deficit Per FS | 1055970 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 3424805 | TotRevenueEtcAuditedFinclStmt |
| Donated Srvc And Use Of Facilities | 46421 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | 18613 | OtherRevenues |
| Revenue Not Rptd F990 | 65034 | RevenueNotRptdF990 |
| Revenue Subtotal | 3359771 | RevenueSubtotal |
| Revenue Not Rptd On Fin Stmt | 0 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 3359771 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 2368835 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 46421 | DonatedServicesUseOfFacilities |
| Other Expenses Included | 18613 | OtherExpensesIncluded |
| Expenses Not Rptd F990 | 65034 | ExpensesNotRptdF990 |
| Expenses Subtotal | 2303801 | ExpensesSubtotal |
| Expenses Not Rptd On Fin Stmt | 0 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 2303801 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| Part V, Line 4: | Description of Intended Use of Endowment Funds: | THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH WAS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS. |
| Part X: | Description of Uncertain Tax Positions Under FIN 48: | Management did not identify any uncertain income tax positions warranting a liability accrual on the financial statements. The Foundation believes it is no longer subject to U.S. Federal, state, and local income tax examinations by taxing authorities for years beginning before 2006. |
| Part XII, Line 2d - Other Adjustments: | special event direct expenses: 18613. | |
| Part XIII, Line 2d - Other Adjustments: | special event direct expenses: 18613. |
Schedule G IRS990ScheduleG
Events Information EventsInformation
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Event1 | WALTER JONES GOLF CLASSIC | NameOfEvent1 |
| Gross Receipts Event1 | 41507 | GrossReceiptsEvent1 |
| Charitable Contributions Event1 | 32747 | CharitableContributionsEvent1 |
| Gross Revenue Event1 | 8760 | GrossRevenueEvent1 |
| Rent Facility Costs Event1 | 11101 | RentFacilityCostsEvent1 |
| Other Direct Expenses Event1 | 7512 | OtherDirectExpensesEvent1 |
| Gross Receipts Total | 41507 | GrossReceiptsTotal |
| Charitable Contributions Total | 32747 | CharitableContributionsTotal |
| Gross Revenue Total Events | 8760 | GrossRevenueTotalEvents |
| Rent Facility Costs Total Events | 11101 | RentFacilityCostsTotalEvents |
| Other Direct Expenses Total Events | 7512 | OtherDirectExpensesTotalEvents |
| Direct Expense Summary Events | 18613 | DirectExpenseSummaryEvents |
| Net Income Summary | -9853 | NetIncomeSummary |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 1 | RecordsMaintained |
Recipient Table RecipientTable (28 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant |
|---|---|---|---|---|---|---|---|
| ALLINA HOSPITALS AND CLINICS | |||||||
| PO Box 43 | Minneapolis | MN | 55440 | 363261413 | 501(C)(3) | 12910 | 2009 medication safety grant |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |||||||
| 7272 Wisconsin Ave | BETHESDA | MD | 20814 | 520807628 | 501(C)(6) | 26682 | clinical skills competition grant |
| ARIZONA BOARD OF REGENTS | |||||||
| PO BOX 3308 | TUCSON | AZ | 857223308 | 860779656 | 501(C)(3) | 39277 | jr investigator grant; pharmacist value grants |
| BIOMEDICAL RESEARCH INSTITUTE OF NEW MEXICO | |||||||
| 1501 SAN PEDRO DRIVE SE | ALBUQUERQUE | NM | 87108 | 850374063 | 501(C)(3) | 6753 | JR INVESTIGATOR GRANT |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501(C)(3) | 39852 | research grant-medical errors by emergency dept physicians |
| CINCINNATI FOUNDATION FOR BIOMEDICAL RESEARCH AND EDUCATION | |||||||
| 3200 VINE STREET | CINCINNATI | OH | 45220 | 311347969 | 115 | 8500 | FEDERAL SERVICES GRANT |
| CLEVELAND CLINICAL FOUNDATION | |||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | 340174585 | 501(C)(3) | 16999 | HOSPITALIST GRANT |
| Duke University Medical Center | |||||||
| 2301 Erwin Road | durham | NC | 27705 | 562070036 | 501(C)(3) | 11000 | preceptor fees: antithrombotic traineeship, oncology traineeship |
| EDWARD FOUNDATION | |||||||
| 801 S WASHINGTON | NAPERVILLE | IL | 60540 | 363723705 | 501(C)(3) | 13480 | MEDICATION SAFETY GRANT |
| Henry Ford Hospital | |||||||
| 2799 west grand blvd | detroit | MI | 48238 | 381357020 | 501(C)(3) | 10000 | award for excellence grant |
| THE JOHNS HOPKINS HOSPITAL | |||||||
| 600 N WOLFE STREET | BALTIMORE | MD | 21287 | 520591656 | 501(C)(3) | 10000 | preceptor fees: ONCOLOGY TRAINEESHIP |
| KAISER PERMANENTE COLORADO | |||||||
| 16601 E CENTRETECH PKWY | AURORA | CO | 800119045 | 840591617 | 6520 | JUNIOR INVESTIGATOR GRANT | |
| KALEIDA HEALTH | |||||||
| 100 high Street | Buffalo | NY | 14203 | 161533232 | 501(C)(3) | 50000 | award for excellence grant |
| MAYO CLINIC | |||||||
| 200 First Street SW | rochester | MN | 55905 | 416011702 | 501(C)(3) | 21500 | grants-emergency physician, pharmacy resident |
| MERITER HOSPITAL PHARMACY DEPARTMENT | |||||||
| 202 s park street | madison | WI | 53715 | 390806367 | 501(C)(3) | 8000 | preceptors fee: antithrombotic traineeship |
| Palo Alto Institute for Research & Education | |||||||
| 431 Florence 200 | Palo Alto | CA | 94301 | 770207331 | 501(C)(3) | 8250 | jr investigator grant |
| REGENTS OF UNIVERSITY OF CALIFORNIA | |||||||
| 521 PARNASSUS AVENUE | SAN FRANCISCO | CA | 941430622 | 946036493 | 501(C)(3) | 16396 | PRECEPTORS FEE: antithrombotic traineeship |
| rex healthcare institute | |||||||
| 4420 Lake Boone Trail | Raleigh | NC | 27607 | 566052117 | 501(C)(3) | 10000 | award for excellence grant |
| SAINT LUKE'S EPISCOPAL HOSPITAL | |||||||
| 6720 BERTNER | HOUSTON | TX | 77030 | 741161938 | 501(C)(3) | 13080 | medication safety grant |
| UNIVERSITY OF CALIFORNIA SAN DIEGO MEDICAL CENTER | |||||||
| 200 WEST ARBOR DRIVE | SAN DIEGO | CA | 92103 | 956006144 | 501(C)(3) | 13480 | medication safety grant |
| UNIVERSITY OF IOWA | |||||||
| 4 jessup hall | iowas city | IA | 52242 | 426004813 | 501(C)(3) | 13200 | medication safety team grant |
| UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER | |||||||
| 1200 N Phillips Ave | Oklahoma City | OK | 73104 | 736017987 | 501(C)(3) | 5000 | pharmacy resident grant |
| UNIVERSITY OF ROCHESTER MEDICAL CENTER | |||||||
| 601 Elmwood Ave | rochester | NY | 14642 | 160743209 | 501(C)(3) | 16500 | emergency physician grant |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | |||||||
| 1515 holcombe blvd | houston | TX | 77030 | 746000203 | 501(C)(3) | 5000 | pharmacy resident grant |
| UNIVERSITY OF WASHINGTON MEDICAL CENTER | |||||||
| 1959 NE Pacific street | seattle | WA | 98101 | 916001537 | 501(C)(3) | 9000 | preceptor fees: antithrombotic and oncology traineeships |
| VA WESTERN NY HEALTHCARE SYSTEM | |||||||
| 3495 Bailey Ave | buffalo | NY | 14215 | 161447141 | 501(C)(3) | 10000 | preceptor fees: antithrombotic traineeship |
| VIRGINIA COMMONWEALTH UNIVERSITY | |||||||
| PO BOX 980568 | RICHMOND | VA | 232980568 | 546001758 | 115 | 6533 | JUNIOR INVESTIGATOR GRANT |
| WISHARD MEMORIAL FOUNDATION INC | |||||||
| 1001 WEST 10TH STREET | iNDIANAPOLIS | IN | 462022879 | 311132066 | 501(C)(3) | 13198 | medication safety grant |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 26 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 2 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part III Form990ScheduleIPartIII (5 entries)
| Type Of GrantTypeOfGrant | Number Of RecipientsNumberOfRecipients | Amount Of Cash GrantAmountOfCashGrant |
|---|---|---|
| leadership honoraria | 10 | 25900 |
| literature awards program | 9 | 17500 |
| multisite special honoraria | 6 | 2314 |
| student leadership awards | 24 | 30000 |
| oncology honoraria | 2 | 1000 |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Procedure for Monitoring Grants in the U.S.: | Identifier |
| Return Reference | Part I, Line 2: | ReturnReference |
| Explanation | Schedule I, Part I, Line 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | X | CompensationCommittee |
| Form990 Of Other Organizations | X | Form990OfOtherOrganizations |
| Written Employment Contract | X | WrittenEmploymentContract |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | 0 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 0 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 0 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (3 entries)
| Base Compensation Filing OrgBaseCompensationFilingOrg | Comp Based On Related OrgsCompBasedOnRelatedOrgs | Bonus Filing OrgBonusFilingOrg | Bonus Related OrgsBonusRelatedOrgs | Other Compensation Filing OrgOtherCompensationFilingOrg | Other Compensation Related OrgsOtherCompensationRelatedOrgs | Deferred Comp Filing OrgDeferredCompFilingOrg | Deferred Comp Related OrgsDeferredCompRelatedOrgs | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs | Total Compensation Filing OrgTotalCompensationFilingOrg | Total Compensation Related OrgsTotalCompensationRelatedOrgs | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg | Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HENRI R MANASSE JR PHD SCD | |||||||||||||
| 0 | 622498 | 0 | 0 | 0 | 21701 | 0 | 60197 | 0 | 21997 | 0 | 726393 | 0 | 0 |
| STEPHEN J ALLEN MS FASHP | |||||||||||||
| 207236 | 0 | 0 | 0 | 10140 | 0 | 24284 | 0 | 9529 | 0 | 251189 | 0 | 0 | 0 |
| RICHARD WALLING | |||||||||||||
| 133929 | 0 | 0 | 0 | 1707 | 0 | 14825 | 0 | 2133 | 0 | 152594 | 0 | 0 | 0 |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (7 entries)
| IdentifierIdentifier | ExplanationExplanation |
|---|---|
| Form 990, Part VI, Section A, line 2 | Business relationship - Michael S. Flagstead and Lynnae M. Mahaney. |
| Form 990, Part VI, Section A, line 7a | THREE MANDATORY MEMBERS OF THE FOUNDATIONS BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. |
| Form 990, Part VI, Section A, line 8b | THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. |
| Form 990, Part VI, Section B, line 11 | THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS. |
| Form 990, Part VI, Section B, line 12c | ANNUALLY AT THE MARCH MEETING |
| Form 990, Part VI, Section B, line 15a | CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVAULATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE COORDINATES A 360-DEGREE PERFORMANCE REVIEW, SECURING INPUT FROM THE FOUNDATION AND ASHP STAFF, FOUNDATION VOLUNTEERS, AND REPRESENTATIVES FROM THE CORPORATE COMMUNITY WHO HAVE SPONSORED PROGRAMS FOR THE FOUNDATION. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE 360-DEGREE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR CHIEF PHARMACY OFFICERS SINCE THIS IS A LIKELY AND COMPETITIVE CANDIDATE POOL FOR THE CEO POSITION, 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION, AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARDS CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARAMCIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP. |
| Form 990, Part VI, Section C, line 19 | THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST. |
Schedule R IRS990ScheduleR
Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivities | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Direct Controlling Entity NADirectControllingEntityNA | Business Name Line1DirectControllingEntityName/BusinessNameLine1 |
|---|---|---|---|---|---|---|---|---|---|
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) | |||||||||
| 7272 WISCONSIN AVENUE | BETHESDA | MD | 20814 | 520807628 | TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION | MD | 501(C)(6) | N/A | |
| 7272 WISCONSIN BUILDING CORPORATION | |||||||||
| 7272 WISCONSIN AVENUE | BETHESDA | MD | 20814 | 521760057 | TITLE HOLDING COMPANY | MD | 501(C)(2) | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | 0 | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | 1 | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | 1 | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | 0 | LoansOrGuaranteesFromOtherOrg |
| Sale Of Assets To Other Org | 0 | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | 0 | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | 0 | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | 0 | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | 0 | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | 0 | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | 0 | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | 1 | SharingOfFacilities |
| Sharing Of Paid Employees | 1 | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | 1 | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | 0 | OtherTransferToOtherOrg |
| Other Transfer From Other Org | 1 | OtherTransferFromOtherOrg |
Transactions Related Orgs Table TransactionsRelatedOrgsTable (6 entries)
| Transaction TypeTransactionType | Amount InvolvedAmountInvolved |
|---|---|
| aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| O | 1256531 |
| aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| M | 672406 |
| aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| R | 584125 |
| aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| C | 321500 |
| aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| N | 46421 |
| aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| B | 26682 |
Comments